IIS Biobizkaia is a leading biomedicine research institute located in Barakaldo, Spain, dedicated to advancing health and medical science. With a strong focus on primary health care, chronic disease prevention, and aging, the institute plays a pivotal role in innovative research across various medical fields, including cancer, endocrinology, autoimmune diseases, and neurodegenerative disorders. IIS Biobizkaia is committed to enhancing patient care through groundbreaking studies in maternal and child health, reproductive assistance, and biomedical engineering.

Equipped with state-of-the-art omics platforms and a technological hub known as 2HBT, the institute emphasizes international collaboration, innovation, and the direct transfer of knowledge into clinical practices. By fostering strong partnerships and offering a range of services from clinical research to patient engagement initiatives, IIS Biobizkaia is at the forefront of improving healthcare outcomes. Their dedication to transparency and continuous professional development positions them as a prominent entity in the biomedical community and a trusted resource for researchers and healthcare professionals alike.